Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s traded shares stood at 0.69 million during the last session, with the company’s beta value hitting 2.33. At the close of trading, the stock’s price was $1.20, to imply an increase of 7.14% or $0.08 in intraday trading. The CDT share’s 52-week high remains $392.00, putting it -32566.67% down since that peak but still an impressive 9.17% since price per share fell to its 52-week low of $1.09.

Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information

After registering a 7.14% upside in the last session, Conduit Pharmaceuticals Inc (CDT) has traded red over the past five days. The 5-day price performance for the stock is 4.35%, and -56.52% over 30 days. With these gigs, the year-to-date price performance is -82.51%.

CDT Dividends

Conduit Pharmaceuticals Inc has its next earnings report out in April. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

We also have Fidelity Small Cap Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Conduit Pharmaceuticals Inc (CDT) shares. Going by data provided on Oct 31, 2024 , Fidelity Small Cap Index Fund holds roughly 2.33 shares. This is just over 0.06% of the total shares, with a market valuation of $2800.0. Data from the same date shows that the other fund manager holds a little less at 2.03, or 0.06% of the shares, all valued at about 2434.0.